Trial Profile
Clinical Trials Insight: 700028285
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 22 Aug 2023
Price :
$35
*
At a glance
- Drugs GSK 2190914 (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Amira Pharmaceuticals
- 08 Nov 2007 New trial record.